Viewing Study NCT00000935


Ignite Creation Date: 2025-12-24 @ 10:07 PM
Ignite Modification Date: 2026-01-25 @ 1:49 AM
Study NCT ID: NCT00000935
Status: COMPLETED
Last Update Posted: 2017-01-11
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None End-Stage Renal Disease View
None Kidney Transplantation View
Keywords: